• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    AVEO Pharmaceuticals, Inc. (AVEO)

    1.42 Down 0.12(7.79%) Mar 5, 4:00PM EST
    |Pre-Market : 1.40 Down 0.02 (1.41%) 7:33PM EST - Nasdaq Real Time Price
    Add to Portfolio
    HeadlinesGet Headlines for:
    [audio] [audio] AVEO Oncology Biomarker Analysis from Phase 2 Clinical Study of Tivozanib in Patients with Advanced Colorectal Cancer (live today at 8:00 am ET)

    No headlines available for AVEO prior to May 8, 2013.